Enveric Biosciences, Inc. · NASDAQ:ENVB
Lind Global Fund III LP reported a 9.99% stake in Enveric Biosciences, Inc. (Schedule 13G)
Event Jan 28, 2026 · Filed Feb 4, 2026
Lind Global Fund III LP reported a 9.99% stake in Enveric Biosciences, Inc., 141,265 shares, as a passive investor on Jan 28, 2026. Filed Feb 4, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 141,265
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lind Global Fund III LP | 9.99% | 141,265 |
| Lind Global Partners III LLC | 9.99% | 141,265 |
| EASTON JEFF | 9.99% | 141,265 |
Source
Related
- Enveric Biosciences, Inc.
- Lind Global Fund III LP
- Enveric Biosciences, Inc. shareholders
- Schedule 13G/A · Lind Global Fund III LP · Aug 14, 2026
- Schedule 13G/A · Lind Global Fund III LP · May 15, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Ayrton Capital LLC · Aug 13, 2026
- Form 4 · Coveney Kevin Michael · Jun 3, 2026
- Form 4 · Tucker Joseph Edward · Jun 3, 2026
- Form 4 · Pasqualone Frank · Jun 3, 2026